athenahealth, Inc (ATHN) Insider Sells $157,764.99 in Stock
athenahealth, Inc (NASDAQ:ATHN) insider Daniel P. Haley sold 1,153 shares of the company’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $136.83, for a total value of $157,764.99. Following the sale, the insider now owns 12,436 shares of the company’s stock, valued at $1,701,617.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Shares of athenahealth, Inc (ATHN) traded up $2.69 during trading on Monday, hitting $141.75. The stock had a trading volume of 511,891 shares, compared to its average volume of 566,374. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $5,680.00, a P/E ratio of 114.31, a PEG ratio of 2.41 and a beta of 1.17. athenahealth, Inc has a 12 month low of $95.01 and a 12 month high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $0.62 earnings per share. sell-side analysts expect that athenahealth, Inc will post 2.69 earnings per share for the current year.
A number of research firms have recently commented on ATHN. BidaskClub upgraded athenahealth from a “sell” rating to a “hold” rating in a report on Saturday, December 16th. Piper Jaffray Companies reiterated a “buy” rating and issued a $160.00 price target on shares of athenahealth in a report on Friday, February 16th. Canaccord Genuity increased their price target on athenahealth from $123.00 to $137.00 and gave the company a “hold” rating in a report on Thursday, February 1st. Citigroup started coverage on athenahealth in a report on Thursday, January 4th. They issued a “neutral” rating for the company. Finally, Royal Bank of Canada set a $141.00 price target on athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. Three analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $144.35.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.